
John P. Cooke MD PhD
Vascular Medicine
Chair, Department of Cardiovascular Sciences Director, Center for Cardiovascular Regeneration The Methodist Hospital Research Institute
Join to View Full Profile
6550 Fannin StreetSuite 1401Houston, TX 77030
Phone+1 713-441-5200
Fax+1 713-793-7428
Dr. Cooke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Cooke is Professor and Chair of the Department of Cardiovascular Sciences; Director, Center for Cardiovascular Regeneration; Medical Director, RNA Therapeutics Program; at Houston Methodist Research Institute; Weill Cornell Medical College; Adjunct Professor, Texas A&M School of Medicine.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1983 - 1987
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1980 - 1982
- Wayne State University School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1990 - Present
- TX State Medical License 2015 - 2026
- MN State Medical License 1981 - 1988
- IA State Medical License 1983 - 1986
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease Start of enrollment: 2004 Apr 01
Publications & Presentations
PubMed
- Circular RNA Telomerase Reverses Endothelial Senescence in Progeria.Weifeng Qin, Kathrina D Castillo, Hongye Li, Thi Kim Cuc Nguyen, Daniel L Kiss
Aging Cell. 2025-02-23 - Telomerase mRNA Reduces Radiation-induced DNA Damage of human skin.David F Chang, Shuang Li, Karem Court Pinto, Thi Kim Cuc Nguyen, Vrutant V Shah
Biorxiv. 2025-02-03 - 1 citationsApplication of validated size-exclusion chromatography method for physicochemical characterization of topical gel formulation of deferoxamine conjugated with PEGylated...Adnan A Khan, Eman M Mohamed, Mohammad Kashif Iqubal, James M Tour, Emily A McHugh
International Journal of Pharmaceutics. 2024-12-05
Journal Articles
- Original Investigation Editorial Comment Novel Markers for Adverse Events in Atrial Fibrillation∗John Cooke, MD, ScienceDirect
Press Mentions
- Vaccination Tied to Shorter COVID Illness, Less Viral SheddingOctober 18th, 2022
- Houston Hospitals, Pharmacies to Soon Offer New COVID-19 Shots Targeting Omicron, BA.5 VariantsAugust 31st, 2022
- JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. To Scientific Advisory BoardJune 15th, 2021
- Join now to see all
Grant Support
- Premature aging disorders, metabolites, and atherosclerosisUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
- Premature aging disorders, metabolites, and atherosclerosisUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
- Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chipBOSTON UNIVERSITY MEDICAL CAMPUS2021–2025
- Cell Characterization And Imaging For Regenerative Therapies In Ischemic DiseasesNational Heart, Lung, And Blood Institute2012
- Mechanisms In Innovation In Vascular DiseaseNational Heart, Lung, And Blood Institute2011
- The Role Of The Nicotinic Cholinergic Pathway In Retinopathy Of PrematurityNational Eye Institute2011
- Basic And Translational Research Ipsc-Based Hematologic And Vascular TherapiesNational Heart, Lung, And Blood Institute2009–2011
- Stanford Career Development In Vascular MedicineNational Heart, Lung, And Blood Institute2007–2011
- Nce-Based Strategy For Nuclear Reprogramming And Regenerative MedicineNational Heart, Lung, And Blood Institute2009–2010
- Core--Clinical Research Skills DevelopmentNational Heart, Lung, And Blood Institute2006–2010
- Translational Research And Education In Cell Therapies For Vascular RegenerationNational Heart, Lung, And Blood Institute2009
- Signal-Transduction Of Endothelial Nachr In AngiogenesisNational Cancer Institute2005–2008
- ADMA: An Endogenous Inhibitor Of ESC Differentiation And EC RegenerationNational Heart, Lung, And Blood Institute2007
- Therapeutic Manipulation Of The NOS Pathway In Peripheral Arterial DiseaseNational Center For Research Resources2005–2007
- Stanford Vascular Biology And Medicine Training GrantNational Heart, Lung, And Blood Institute2003–2007
- Genetic Determinants Of PADNational Heart, Lung, And Blood Institute2003–2007
- ADMA: An Endogenous Inhibitor ESC Differentiation And ECNational Heart, Lung, And Blood Institute2006
- Effect Of ADMA And L-ArginineNational Center For Research Resources2006
- Heart Transplant Patients - Role Of Dysregulation Of The Nitric Oxide SynthaseNational Center For Research Resources2005
- Development Of Insulin Resistance In Patients With Peripheral Arterial DiseaseNational Center For Research Resources2005
- Peripheral Endothelial Vasomotor Function In TransplantsNational Center For Research Resources2004
- Manipulation Of The NOS Pathway In Arterial Disease-Dose-Ranging STUDY.National Center For Research Resources2004
- Double-Blind Placebo-Controlled Study Of Oral L-ArginineNational Center For Research Resources2004
- Phase 2: NOS Pathway In Arterial DiseaseNational Heart, Lung, And Blood Institute2003–2004
- Manipulation Of The NOS Pathway In Arterial DiseaseNational Heart, Lung, And Blood Institute2000–2004
- CMV And Dysregulation Of The NOS PathwayNational Institute Of Allergy And Infectious Diseases2001–2002
- Stanford Vascular Biology &Medicine Training GrantNational Heart, Lung, And Blood Institute1997–2001
- Vascular Disease Academic AwardNational Heart, Lung, And Blood Institute1991–1995
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: